HROW vs NOK · rev $114.9M vs P/E 87, $78.04B cap
Harrow Health Inc (HROW) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
NOK does not have a complete income-statement cache yet.
HROW currently screens at market cap $1.28B. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the HROW and NOK stock pages for the full models.
Not investment advice.